(Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced positive interim results from two Phase 1b studies of its investigational ...

Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.

Chemists have long been fascinated and frustrated by saxitoxin: a molecule that causes temporary paralysis by blocking the ...

That’s the big idea behind Zymosense, “The Nanoassay Company,” a startup that’s spinning off technology developed in the lab ...

For decades, Arieh Warshel, USC Distinguished Professor of Chemistry and a 2013 Nobel laureate, has used computer simulations ...

Nobel laureate David Baker’s latest foundation model can design proteins that interact to any biomolecule for broad biotech applications.

An AI-driven computational toolkit, Gcoupler, integrates ligand design, statistical modeling, and graph neural networks to predict endogenous metabolites that allosterically modulate the GPCR–Gα ...

David Baker's lab at the University of Washington is announcing two major leaps in the field of AI-powered protein design.

Inside every human cell, six feet of DNA folds into a nucleus that is only a few micrometers wide, yet still manages to ...

With seed money from Crider Foods, Inc., a multidisciplinary research team led by Dr. Kamran Kardel is working with regional ...